Mstn, a growth factor expressed in skeletal muscles, negatively modulates muscle mass; hence, its inhibition was a potential therapeutic treatment against muscle wasting [80,81,82] or Duchenne muscular dystrophy (DMD) [83,84,85]. Here, MSTN is linked to Duchenne muscular dystrophy.